Complement in central nervous system inflammation

Immunologic Research

Volumn 26, Issue 1-3, 2002, Pages 7-13

  Barnum, Scott R ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Anaphylatoxin receptors; Complement; Experimental allergic encephalomyelitis; Glial cells; Neurobiology; Neurons

Indexed keywords

COMPLEMENT COMPONENT C3 RECEPTOR; COMPLEMENT COMPONENT C3A RECEPTOR; COMPLEMENT COMPONENT C5A RECEPTOR; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; DEMYELINATING DISEASE; GLIA CELL; INFLAMMATION; MULTIPLE SCLEROSIS; NERVE CELL; NEUROBIOLOGY; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0036395938     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/ir:26:1-3:007     Document Type: Article

References (39)

1. Carroll MC: The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol 1998;16:545-568.
2. Song WC, Sarrias MR, Lambris JD: Complement and innate immunity. Immunopharmacology 2000;49:187-198.
3. Morgan BP, Gasque P: Extrahepatic complement biosynthesis: where, when and why? Clin Exp Immunol 1997;107:1-7.
4. Naughton MA, Botto M, Carter MJ, Alexander GJ, Goldman JM, Walport MJ: Extrahepatic secreted complement C3 contributes to circulating C3 levels in humans. J Immunol 1996;156:3051-3056.
5. Zwirner J, Fayyazi A, Gotze O: Expression of the anaphylatoxin C5a receptor in non-myeloid cells. Mol Immunol 1999;36:877-884.
6. Whaley K, Schwaeble W: Complement and complement deficiencies. Semin Liver Dis 1997;17:297-310.
7. Schmidt BZ, Colten HR: Complement: a critical test of its biological importance. Immunol Rev 2000;178:166-176.
8. Zhou W, Marsh JE, Sacks SH: Intrarenal synthesis of complement. Kidney Int 2001;59:1227-1235.
9. Yasojima K, Schwab C, McGeer EG, McGeer PL: Up-regulated production and activation of the complement system in Alzheimer's disease brain. Am J Pathol 1999;154:927-936.
10. Barnum SR: Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease. Mol Med 1999;5:569-582.
11. Nataf S, Stahel PF, Davoust N, Barnum SR: Complement anaphylatoxin receptors on neurons: new tricks for old receptors? Trends Neurosci 1999;22:397-402.
12. Gasque P, Dean YD, McGreal EP, VanBeek J, Morgan BP: Complement components of the innate immune system in health and disease in the CNS. Immunopharmacology 2000;49:171-186.
13. Shin ML, Rus H, Niculescu F: Complement system in central nervous system disorders, in Volanakis JE, Frank MM (eds): The Human Complement System in Health and Disease. New York, Marcel Dekker, 1998, pp. 499-525.
14. Barnum SR: The complement system in demyelinating disease: new insights from transgenic and complement-deficient mice, in Bondy S, Campbell A (eds): Inflammatory Events in Neurodegeneration. Scottsdale, AZ, Prominent Press, 2001, pp. 139-156.
15. Campbell IL, Stalder AK, Akwa Y, Pagenstecher A, Asensio VC: Transgenic models to study the actions of cytokines in the central nervous system. Neuroimmunomodulation 1998;5:126-135.
16. Davoust N, Nataf S, Reiman R, Holers MV, Campbell IL, Barnum SR: Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis. J Immunol 1999;163:6551-6556.
17. Circolo A, Garnier G, Fukuda W, Wang X, Hidvegi T, Szalai AJ, Briles DE, Volanakis JE, Wetsel RA, Colten HR: Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA. Immunopharmacology 1999;42:135-149.
18. Matsumoto M, Fukuda W, Circolo A, Goellner J, Strauss-Schoenberger J, Wang X, Fujita S, Hidvegi T, Chaplin DD, Colten HR: Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc Natl Acad Sci USA 1997;94:8720-8725.
19. Nataf S, Carroll SL, Wetsel RA, Szalai AJ, Barnum SR: Attenuation of experimental autoimmune demyelination in complement-deficient mice. J Immunol 2000;165:5867-5873.
20. Calida DM, Constantinescu C, Purev E, Zhang GX, Ventura ES, Lavi E, Rostami A: Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice. J Immunol 2001;166:723-726.
21. Campos Torres A, Reiman R, Martin B, Campbell IL, Barnum SR: Characterization of transgenic mice over-expressing the complement anaphylatoxin C5a in the CNS. Immunopharmacology 2000;49:48.
22. Boos L, Campos Torres A, Ames R, Campbell IL, Barnum SR: Characterization of transgenic mice over-expressing the complement anaphylatoxin C3a in the CNS. J Neuroimmunol 2001;118:11.
23. Reiman R, Campos Torres A, Ting J, Martin B, Campbell IL, Barnum SR: Experimental allergic encephalomyelitis in mice over-expressing the complement anaphylatoxin CSa in the CNS. J Neuroimmunol 2001;118:20.
24. Tocco G, Musleh W, Sakhi S, Schreiber SS, Baudry M, Pasinetti GM: Complement and glutamate neurotoxicity: genotypic influences of C5 in a mouse model of hippocampal neurodegeneration. Mol Chem Neuropathol 1997;31:289-300.
25. Pasinetti GM, Tocco G, Sakhi S, Musleh WD, DeSimoni MG, Mascarucci P, Schreiber S, Baudry M, Finch CE: Hereditary deficiencies in complement C5 are associated with intensified neurodegenerative responses that implicate new roles for the C-system in neuronal and astrocytic functions. Neurobiol Dis 1996;3:197-204.
26. Osaka H, Mukherjee P, Aisen PS, Pasinetti GM: Complement-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity. J Cell Biochem 1999;73:303-311.
27. Osaka H, McGinty A, Hoepken UE, Lu B, Gerard C, Pasinetti GM: Expression of C5a receptor in mouse brain: role in signal transduction and neurodegeneration. Neuroscience 1999;88:1073-1082.
28. Pasinetti GM: Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: the role of the complement system. Neurobiol Aging 1996;17:707-716.
29. Mukherjee P, Pasinetti GM: Complement anaphylatoxin C5a neuroprotects through mitogen-activated protein kinase-dependent inhibition of caspase 3. J Neurochem 2001;77:43-49.
30. Mukherjee P, Pasinetti GM: The role of complement anaphylatoxin C5a in neurodegeneration: implications in Alzheimer's disease. J Neuroimmunol 2000;105:124-130.
31. O'Barr SA, Caguioa J, Gruol D, Perkins G, Ember JA, Hugli T, Cooper NR: Neuronal expression of a functional receptor for the C5a complement activation fragment. J Immunol 2001:166:4154-4162.
32. Heese K, Hock C, Otten U: Inflammatory signals induce neurotrophin expression in human microglial cells. J Neurochem 1998;70:699-707.
33. Boos L, Campos Torres A, Gerard C, Barnum SR: Disruption of the C5a receptor gene has no effect on experimetal allergic encephalomyelitis. J Neuroimmunol 2001;118:11.
34. Stahel PF, Nadal D, Pfister HW, Paradisis PM, Barnum SR: Complement C3 and factor B cerebrospinal fluid concentrations in bacterial and aseptic meningitis. Lancet 1997;349:1886-1887.
35. Davoust N, Jones J, Stahel PF, Ames RS, Barnum SR: Receptor for the C3a anaphylatoxin is expressed by neurons and glial cells. Glia 1999;26:201-211.
36. Campos Torres A, Reiman R, Barnum SR: Distribution the complement anaphylatoxin receptors in the normal mouse CNS. J Neuroimmunol 2001;118:12.
37. Schupf N, Williams CA, Berkman A, Cattell WS, Kerper L: Binding specificity and presynaptic action of anaphylatoxin C5a in rat brain. Brain Behav Immun 1989;3:28-38.
38. Moller T, Nolte C, Burger R, Verkhratsky A, Kettenmann H: Mechanisms of C5a and C3a complement fragment- induced [Ca2+]i signaling in mouse microglia. J Neurosci 1997;17:615-624.
39. Ilschner S, Nolte C, Kettenmann H: Complement factor C5a and epidermal growth factor trigger the activation of outward potassium currents in cultured murine microglia. Neuroscience 1996;73:1109-1120.